Organon & Co | OGN - Pe Kurs-Gewinn

Aktienkurs
6.12
Täglich Wechseln
0.07 1.16%
Monatlich
-6.28%
Jährlich
-47.13%
Q2 Prognose
6.17




Pe Veränderung Datum
Bristol-Myers Squibb 9.28 1.04 2025-12
Celltrion 50.09 23.24 2025-09
Cspc Pharmaceutical 24.4 1.13 2025-12
Deva Holding AS 6.55 2.01 2023-09
Dianthus Therapeutics 3.8 1.53 2024-09
Divis Laboratories Ltd 66.5 5.69 2025-12
Gilead Sciences 15.63 0.08 2025-12
Glaxosmithkline 11.66 0.28 2025-12
Kangmei Pharma 3.15K 624.19 2025-06
Knight Therapeutics 257.34 166.24 2025-12
Laboratorios Farma 18.78 6.64 2023-12
Malin Corporation 11.81 0.72 2023-06
Merck 13.92 5.08 2025-12
Neuren Pharmaceuticals 72.14 59.86 2025-12
Novartis 17.79 1.74 2025-12
Organigram Holdings 235 224.49 2025-09
Organon & Co 3.75 0.87 2025-12
Ovoca Bio 1.83 3.29 2024-06
Pharma Mar 17.41 29.74 2025-12
Qiagen NV 20.54 0.1 2025-12
Sartorius 34.42 122.1 2025-09
Sino Biopharmaceutical 17.03 0.89 2025-06
Tilray 11.56 80.19 2025-09
Zealand Pharma A/S 5.13 0.16 2025-12